These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation. Lange D; Bechstein WO; Blumhardt G; Lemmens P; Schattenfroh N; Neuhaus P Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207 [No Abstract] [Full Text] [Related]
5. Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Gruessner AC; Sutherland DE Clin Transpl; 2008; ():45-56. PubMed ID: 19708445 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous pancreas-kidney transplant from living related donor: a single-center experience. ZieliĆski A; Nazarewski S; Bogetti D; Sileri P; Testa G; Sankary H; Benedetti E Transplantation; 2003 Aug; 76(3):547-52. PubMed ID: 12923442 [TBL] [Abstract][Full Text] [Related]
9. A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. Stratta RJ; Taylor RJ; Weide LG; Sindhi R; Sudan D; Castaldo P; Cushing KA; Frisbie K; Radio SJ Transplant Proc; 1996 Apr; 28(2):917-8. PubMed ID: 8623461 [No Abstract] [Full Text] [Related]
10. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494 [No Abstract] [Full Text] [Related]
11. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
12. Analysis of United States (US) and non-US pancreas transplants as reported to the International Pancreas Transplant Registry (IPTR) and to the United Network for Organ Sharing (UNOS). Gruessner AC; Sutherland DE Clin Transpl; 1998; ():53-73. PubMed ID: 10503085 [TBL] [Abstract][Full Text] [Related]
13. Treatment of steroid resistant rejection following renal transplantation: benefits and risks of OKT3 therapy. Kehinde EO; Feehally J; Scriven SD; Veitch PS; Bell PR Transplant Proc; 1996 Jun; 28(3):1449-50. PubMed ID: 8658735 [No Abstract] [Full Text] [Related]